Phase 1 clinical trial to test a new, potential method against cancer news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: The clinical trial is the first step toward the team s overall goal: Developing a platform that combines radiotherapy with immunotherapy, drugs that help a patient s own immune system fight off. view more
Credit: Creative commons via Pxhere
A potential new weapon against cancer is entering the first phase of clinical trials thanks to a collaboration between Spectrum Health, the Lansing-based company Niowave and Michigan State University.
MSU s Kurt Zinn, a professor of biomedical engineering, radiology and small animal clinical sciences, is leading the effort to validate an innovative radiotherapy as part of a safe, more effective and potentially less costly treatment for bladder cancer.
Need an expert for American Heart Month?
February is American Heart Month, a time to highlight the top cause of death in Americans: heart disease. This year, the American Heart Association is highlighting the “Don’t Die of Doubt” awareness campaign, which focuses on reminding people that, even during the pandemic, hospitals are the safest place to go when symptoms of heart disease crop up.
Included is a list of researchers with expertise on a variety of topics related to heart health, heart medicine research and more. For more experts, contact Zach Richardson, MSU public relations manager, at richa954@msu.edu.
The extraordinary power of What if? msu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msu.edu Daily Mail and Mail on Sunday newspapers.
Nanomedicine targets cardiovascular disease
Michigan State and Stanford researchers have upgraded their Trojan horse therapies designed to fight one of the world’s leading causes of death.
Led by Bryan Smith, an associate professor in MSU’s Department of Biomedical Engineering, the team is building on its nanoscopic tubules that carry drugs to fight atherosclerotic plaques involved in cardiovascular disease.
With the help of some crafty chemistry, the team has enabled the tubes to sense when they’ve successfully entered a cell to release their therapeutic payloads. The team, including first author Yapei Zhang, a postdoctoral fellow in Smith’s lab, published this work online on Nov. 6, 2020, in the journal Nano Research.